Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Item 9 Labs Corp (INLB)

Item 9 Labs Corp (INLB)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 153,638
  • Shares Outstanding, K 90,910
  • Annual Sales, $ 0 K
  • Annual Income, $ 0 K
  • 60-Month Beta 0.85
  • Price/Sales 19.03
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade INLB with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.03
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date N/A
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/21
See More
  • Average Estimate 0.00
  • Number of Estimates 1
  • High Estimate 0.00
  • Low Estimate 0.00
  • Prior Year N/A
  • Growth Rate Est. (year over year) N/A

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.5000 +5.33%
on 09/17/21
2.5000 -36.80%
on 08/27/21
-0.2300 (-12.71%)
since 08/17/21
3-Month
1.5000 +5.33%
on 09/17/21
3.3900 -53.39%
on 06/21/21
-1.6000 (-50.31%)
since 06/17/21
52-Week
0.9900 +59.60%
on 10/12/20
4.0300 -60.79%
on 03/24/21
+0.3600 (+29.51%)
since 09/17/20

Most Recent Stories

More News
Cannabis Deal Tracker: Investment and M&A Activity in the Cannabis Industry August 23rd - August 27th, 2021

 

HEXO.TO : 2.60 (+0.78%)
HEXO : 2.04 (unch)
INLB : 1.5800 (-6.51%)
MJHI : 0.5400 (-10.00%)
Item 9 Labs Corp. Secures $19 Million Construction-Financing Loan with Pelorus Equity Group for Expansion of Cultivation & Lab Sites in Arizona & Nevada

INLB : 1.5800 (-6.51%)
Pelorus Equity Group Announces $19 Million Construction-Financing Loan with Item 9 Labs Corp., a Vertically-Integrated Operator that Produces Award-Winning, Premium Cannabis Products

Pelorus Equity Group ("Pelorus"), the leading provider of value-add bridge commercial real estate loans to cannabis businesses and owners with cannabis-related real estate, announced that its Pelorus Fund,...

INLB : 1.5800 (-6.51%)
Item 9 Labs' Cannabis Cup Win Marks 9 Top Podium Placements

/PRNewswire/ --  (OTCQX: INLB) (the "Company"), a vertically integrated, cannabis dispensary franchisor and operator that produces premium, award-winning products, today announced that it has earned...

INLB : 1.5800 (-6.51%)
Sidoti Microcap Virtual Conference

FLOW : 77.79 (+0.63%)
SOLR.VN : 0.210 (-4.55%)
BLCT : 3.15 (+4.83%)
MG : 9.16 (-3.78%)
VERO : 2.29 (+0.44%)
BKTI : 2.99 (+2.40%)
NVCN : 0.7525 (-2.59%)
ALCO : 35.41 (-0.56%)
CVGI : 9.53 (-0.52%)
FLOW : 77.79 (+0.63%)
VNRX : 3.17 (unch)
LCUT : 17.34 (+0.46%)
NSFDF : 0.5519 (+4.13%)
CSV : 45.76 (-0.52%)
ARHH : 1.5300 (-4.38%)
BSET : 18.48 (+1.26%)
CIDM : 2.23 (-0.45%)
AUUD : 2.69 (-14.33%)
INLB : 1.5800 (-6.51%)
RELL : 9.10 (+1.34%)
AQMS : 2.08 (+2.46%)
GET.CN : 0.330 (+6.45%)
KINS : 7.10 (+3.05%)
VERB : 1.9100 (+1.60%)
BNXAF : 2.4700 (-5.18%)
LOCL.TO : 1.80 (-3.74%)
ABML : 1.3650 (+1.49%)
STAF : 2.06 (-2.37%)
PIXY : 1.2500 (-0.79%)
KNRLF : 1.9148 (-9.68%)
AMST : 1.8000 (-2.17%)
SAMG : 15.69 (-3.39%)
TSQ : 12.53 (-0.32%)
IPWR : 16.16 (+5.35%)
IDW : 3.23 (-11.75%)
GMBL : 7.58 (-3.93%)
STRL : 22.78 (+0.93%)
STRT : 37.97 (+1.25%)
ELVT : 3.46 (unch)
VSQTF : 0.3766 (-0.50%)
DHX : 4.46 (+0.90%)
RICK : 68.60 (+2.17%)
OMQS : 8.99 (-3.75%)
EVC : 7.01 (+2.04%)
BWMX : 37.33 (+1.03%)
NX : 22.25 (+1.14%)
Item 9 Labs Corp. Reports Record Third Quarter FY 2021 Financial Results

/PRNewswire/ --  (OTCQX: INLB) (the "Company"), a vertically integrated cannabis dispensary franchisor and operator that produces premium, award-winning products, today reported operating and financial...

INLB : 1.5800 (-6.51%)
Item 9 Labs to Present at the Sidoti & Company Microcap Investor Conference on August 18

/PRNewswire/ --  (OTCQX: INLB) ("Item 9 Labs" or the "Company"), a vertically integrated, cannabis dispensary franchisor and operator that produces premium, award-winning products, today announced that...

INLB : 1.5800 (-6.51%)
Item 9 Labs to Host its Third Quarter Fiscal Year 2021 Earnings Call on August 17 at 11:00 a.m. ET

/PRNewswire/ --  (OTCQX: INLB) ("Item 9 Labs" or the "Company"), a vertically integrated, cannabis dispensary franchisor and operator that produces premium, award-winning products, today announced that...

INLB : 1.5800 (-6.51%)
Item 9 Labs Adds Multiple Senior Managers to Support Company Growth

/PRNewswire/ --  (OTCQX: INLB) ("Item 9 Labs" or the "Company"), a vertically integrated, cannabis dispensary franchisor and operator that produces premium, award-winning products, today announced...

INLB : 1.5800 (-6.51%)
Item 9 Labs to Present at Issuer Direct's 'Access to Giving' Virtual Investor Conference on July 14, 2021 at 3:00 p.m. ET

/PRNewswire/ --  (OTCQX: ) ("Item 9 Labs" or the "Company"), a vertically integrated cannabis dispensary franchisor and operator that produces premium award-winning products, today announced that...

ISDR : 27.17 (+3.01%)
INLB : 1.5800 (-6.51%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Key Turning Points

3rd Resistance Point 1.7200
2nd Resistance Point 1.6600
1st Resistance Point 1.6200
Last Price 1.5800
1st Support Level 1.5200
2nd Support Level 1.4600
3rd Support Level 1.4200

See More

52-Week High 4.0300
Fibonacci 61.8% 2.8687
Fibonacci 50% 2.5100
Fibonacci 38.2% 2.1513
Last Price 1.5800
52-Week Low 0.9900

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar